Abstract
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex chronic multi-systemic disease characterized by extreme fatigue that is not improved by rest, and worsens after exertion, whether physical or mental. Previous studies have shown ME/CFS-associated alterations in the immune system and mitochondria. We used transmission electron microscopy (TEM) to investigate the morphology and ultrastructure of unstimulated and stimulated ME/CFS immune cells and their intracellular organelles, including mitochondria. PBMCs from four participants were studied: a pair of identical twins discordant for moderate ME/CFS, as well as two age- and gender- matched unrelated subjects—one with an extremely severe form of ME/CFS and the other healthy. TEM analysis of CD3/CD28-stimulated T cells suggested a significant increase in the levels of apoptotic and necrotic cell death in T cells from ME/CFS patients (over 2-fold). Stimulated Tcells of ME/CFS patients also had higher numbers of swollen mitochondria. We also found a large increase in intracellular giant lipid droplet-like organelles in the stimulated PBMCs from the extremely severe ME/CFS patient potentially indicative of a lipid storage disorder. Lastly, we observed a slight increase in platelet aggregation in stimulated cells, suggestive of a possible role of platelet activity in ME/CFS pathophysiology and disease severity. These results indicate extensive morphological alterations in the cellular and mitochondrial phenotypes of ME/CFS patients’ immune cells and suggest new insights into ME/CFS biology.
Funder
National Institutes of Health
Open Medicine Foundation
private donor
Publisher
Public Library of Science (PLoS)
Reference216 articles.
1. Myalgic encephalomyelitis: International Consensus Criteria;BM Carruthers;J Intern Med,2011
2. Symptoms of ME/CFS | Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) | CDC. 9 Feb 2021 [cited 3 Sep 2021]. https://www.cdc.gov/me-cfs/symptoms-diagnosis/symptoms.html
3. The functional status and well being of people with myalgic encephalomyelitis/chronic fatigue syndrome and their carers;LC Nacul;BMC Public Health,2011
4. Functional Status and Well-Being in People with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Compared with People with Multiple Sclerosis and Healthy Controls;CC Kingdon;PharmacoEconomics—Open,2018
5. Redox imbalance links COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome;BD Paul;Proc Natl Acad Sci,2021